MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, COYA has $49,950,245 in assets. $6,922,015 in debts. $46,822,786 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
850.48%
Quick Ratio
850.48%
Cash Ratio
797.41%
Debt to Asset Ratio
13.86%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Fixed assets, net
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Total current liabilities
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
46,822,786
Prepaids and other current assets
3,116,232
Total current assets
49,939,018
Fixed assets, net
11,227
Total assets
49,950,245
Accounts payable
1,061,122
Accrued expenses
3,612,913
Deferred collaboration revenue
1,197,856
Total current liabilities
5,871,891
Deferred collaboration revenue
1,050,124
Total liabilities
6,922,015
Common stock, 0.0001 par value 200,000,000 shares authorized 20,934,456 and 16,707,441 shares issued and outstanding as of december 31, 2025 and 2024, respectively
2,094
Additional paid-in capital
104,989,413
Accumulated deficit
-61,963,277
Total stockholders' equity
43,028,230
Total liabilities and stockholders' equity
49,950,245
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$46,822,786 Prepaids and othercurrent assets$3,116,232 Total current assets$49,939,018 Fixed assets, net$11,227 Total assets$49,950,245 Total liabilities andstockholders' equity$49,950,245 Total stockholders'equity$43,028,230 Total liabilities$6,922,015 Accumulated deficit-$61,963,277 Additional paid-in capital$104,989,413 Total currentliabilities$5,871,891 Deferred collaborationrevenue$1,050,124 Common stock, 0.0001par value...$2,094 Accrued expenses$3,612,913 Deferred collaborationrevenue$1,197,856 Accounts payable$1,061,122

Coya Therapeutics, Inc. (COYA)

Coya Therapeutics, Inc. (COYA)